nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—Voacamine—Vinorelbine—breast cancer	0.402	0.556	CrCrCtD
Rescinnamine—Voacamine—Vinblastine—breast cancer	0.321	0.444	CrCrCtD
Rescinnamine—ACE—umbilical vein—breast cancer	0.00743	0.189	CbGeAlD
Rescinnamine—ACE—arm—breast cancer	0.0065	0.165	CbGeAlD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—MME—breast cancer	0.00255	0.0793	CbGpPWpGaD
Rescinnamine—SLC18A2—endometrium—breast cancer	0.00208	0.0528	CbGeAlD
Rescinnamine—ACE—embryo—breast cancer	0.00194	0.0493	CbGeAlD
Rescinnamine—SLC18A2—uterus—breast cancer	0.00191	0.0487	CbGeAlD
Rescinnamine—SLC18A2—adipose tissue—breast cancer	0.00187	0.0476	CbGeAlD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—CTSD—breast cancer	0.00185	0.0576	CbGpPWpGaD
Rescinnamine—ACE—ACE Inhibitor Pathway—AGTR2—breast cancer	0.00184	0.0573	CbGpPWpGaD
Rescinnamine—SLC18A2—female reproductive system—breast cancer	0.00172	0.0437	CbGeAlD
Rescinnamine—SLC18A2—adrenal gland—breast cancer	0.00168	0.0427	CbGeAlD
Rescinnamine—ACE—epithelium—breast cancer	0.00158	0.0402	CbGeAlD
Rescinnamine—SLC18A2—endocrine gland—breast cancer	0.00146	0.037	CbGeAlD
Rescinnamine—ACE—endometrium—breast cancer	0.00142	0.036	CbGeAlD
Rescinnamine—ACE—ACE Inhibitor Pathway—AGTR1—breast cancer	0.00142	0.044	CbGpPWpGaD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—ALDH1A1—breast cancer	0.00133	0.0414	CbGpPWpGaD
Rescinnamine—ACE—pituitary gland—breast cancer	0.00128	0.0326	CbGeAlD
Rescinnamine—ACE—adipose tissue—breast cancer	0.00128	0.0325	CbGeAlD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—GLI2—breast cancer	0.00119	0.0369	CbGpPWpGaD
Rescinnamine—ACE—female reproductive system—breast cancer	0.00118	0.0299	CbGeAlD
Rescinnamine—ACE—adrenal gland—breast cancer	0.00115	0.0291	CbGeAlD
Rescinnamine—ACE—bone marrow—breast cancer	0.00111	0.0282	CbGeAlD
Rescinnamine—ACE—female gonad—breast cancer	0.00107	0.0272	CbGeAlD
Rescinnamine—SLC18A2—lymph node—breast cancer	0.00101	0.0256	CbGeAlD
Rescinnamine—ACE—endocrine gland—breast cancer	0.000994	0.0253	CbGeAlD
Rescinnamine—ACE—Peptide hormone metabolism—INHBB—breast cancer	0.000917	0.0285	CbGpPWpGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.000868	0.027	CbGpPWpGaD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—WNT1—breast cancer	0.000844	0.0263	CbGpPWpGaD
Rescinnamine—ACE—ACE Inhibitor Pathway—NOS3—breast cancer	0.000731	0.0227	CbGpPWpGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.000719	0.0224	CbGpPWpGaD
Rescinnamine—ACE—lymph node—breast cancer	0.000687	0.0175	CbGeAlD
Rescinnamine—ACE—Peptide hormone metabolism—MME—breast cancer	0.00067	0.0209	CbGpPWpGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.000658	0.0205	CbGpPWpGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.000633	0.0197	CbGpPWpGaD
Rescinnamine—Voacamine—ABCB1—breast cancer	0.000616	0.368	CrCbGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.000545	0.017	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—ACHE—breast cancer	0.000514	0.016	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—CTSD—breast cancer	0.000486	0.0151	CbGpPWpGaD
Rescinnamine—ACE—ACE Inhibitor Pathway—TGFB1—breast cancer	0.000483	0.015	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNN4—breast cancer	0.000457	0.0142	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—BCHE—breast cancer	0.000448	0.0139	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000431	0.0134	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—TCF7L2—breast cancer	0.000416	0.013	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000394	0.0123	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000394	0.0123	CbGpPWpGaD
Rescinnamine—Yohimbine—CYP2D6—breast cancer	0.00039	0.233	CrCbGaD
Rescinnamine—Reserpine—ABCB1—breast cancer	0.000335	0.2	CrCbGaD
Rescinnamine—Yohimbine—CYP3A4—breast cancer	0.000334	0.2	CrCbGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000328	0.0102	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000327	0.0102	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—IGFBP5—breast cancer	0.000301	0.00937	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000299	0.0093	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNH1—breast cancer	0.000295	0.00917	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000288	0.00895	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000288	0.00895	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—EEF1B2—breast cancer	0.000276	0.00857	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—LEP—breast cancer	0.000269	0.00838	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000248	0.00771	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—IGF1—breast cancer	0.000223	0.00692	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000219	0.00682	CbGpPWpGaD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—STAT3—breast cancer	0.000219	0.00681	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ATF4—breast cancer	0.000209	0.0065	CbGpPWpGaD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—TGFB1—breast cancer	0.000203	0.00631	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.0002	0.00624	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.0002	0.00624	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—EIF2S2—breast cancer	0.000188	0.00585	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—INHBB—breast cancer	0.000173	0.00538	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CCT5—breast cancer	0.000173	0.00538	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—ACHE—breast cancer	0.000171	0.00533	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000166	0.00517	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—COX11—breast cancer	0.000166	0.00517	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—CTNNB1—breast cancer	0.000165	0.00514	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—EEF2—breast cancer	0.000165	0.00514	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—RPL31—breast cancer	0.000155	0.00483	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000152	0.00473	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—BCHE—breast cancer	0.000149	0.00464	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000149	0.00464	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000146	0.00455	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000146	0.00455	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—RPS4X—breast cancer	0.000145	0.0045	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—DDIT3—breast cancer	0.000143	0.00443	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—EIF3A—breast cancer	0.000143	0.00443	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ADAMTS1—breast cancer	0.000138	0.0043	CbGpPWpGaD
Rescinnamine—Dizziness—Vinblastine—breast cancer	0.000137	0.000674	CcSEcCtD
Rescinnamine—Urticaria—Vinorelbine—breast cancer	0.000137	0.000673	CcSEcCtD
Rescinnamine—Abdominal pain—Vinorelbine—breast cancer	0.000137	0.00067	CcSEcCtD
Rescinnamine—Pruritus—Goserelin—breast cancer	0.000136	0.000669	CcSEcCtD
Rescinnamine—Oedema—Fluorouracil—breast cancer	0.000136	0.000669	CcSEcCtD
Rescinnamine—Infection—Fluorouracil—breast cancer	0.000136	0.000665	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Thiotepa—breast cancer	0.000135	0.000661	CcSEcCtD
Rescinnamine—Nausea—Chlorambucil—breast cancer	0.000135	0.000661	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—MUC2—breast cancer	0.000135	0.00419	CbGpPWpGaD
Rescinnamine—Rhinitis—Capecitabine—breast cancer	0.000135	0.00066	CcSEcCtD
Rescinnamine—Hypoaesthesia—Capecitabine—breast cancer	0.000134	0.000655	CcSEcCtD
Rescinnamine—Dizziness—Tamoxifen—breast cancer	0.000134	0.000655	CcSEcCtD
Rescinnamine—Pharyngitis—Capecitabine—breast cancer	0.000133	0.000653	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—ACHE—breast cancer	0.000131	0.00408	CbGpPWpGaD
Rescinnamine—Urticaria—Thiotepa—breast cancer	0.000131	0.000643	CcSEcCtD
Rescinnamine—Dermatitis bullous—Doxorubicin—breast cancer	0.000131	0.000642	CcSEcCtD
Rescinnamine—Abdominal pain—Thiotepa—breast cancer	0.00013	0.000639	CcSEcCtD
Rescinnamine—Headache—Vinblastine—breast cancer	0.00013	0.000638	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.00013	0.000636	CcSEcCtD
Rescinnamine—Insomnia—Irinotecan—breast cancer	0.000129	0.000632	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—PABPC1—breast cancer	0.000128	0.00398	CbGpPWpGaD
Rescinnamine—Paraesthesia—Mitoxantrone—breast cancer	0.000128	0.000627	CcSEcCtD
Rescinnamine—Paraesthesia—Irinotecan—breast cancer	0.000128	0.000627	CcSEcCtD
Rescinnamine—Dizziness—Goserelin—breast cancer	0.000128	0.000625	CcSEcCtD
Rescinnamine—Rash—Tamoxifen—breast cancer	0.000127	0.000624	CcSEcCtD
Rescinnamine—Hypersensitivity—Vinorelbine—breast cancer	0.000127	0.000624	CcSEcCtD
Rescinnamine—Dermatitis—Tamoxifen—breast cancer	0.000127	0.000624	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—MME—breast cancer	0.000127	0.00394	CbGpPWpGaD
Rescinnamine—Headache—Tamoxifen—breast cancer	0.000127	0.00062	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000126	0.00062	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000126	0.00392	CbGpPWpGaD
Rescinnamine—Insomnia—Gemcitabine—breast cancer	0.000126	0.000615	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—TUBB3—breast cancer	0.000125	0.00389	CbGpPWpGaD
Rescinnamine—Rash—Melphalan—breast cancer	0.000125	0.000611	CcSEcCtD
Rescinnamine—Paraesthesia—Gemcitabine—breast cancer	0.000125	0.000611	CcSEcCtD
Rescinnamine—Dermatitis—Melphalan—breast cancer	0.000125	0.000611	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000124	0.00061	CcSEcCtD
Rescinnamine—Cough—Paclitaxel—breast cancer	0.000124	0.000609	CcSEcCtD
Rescinnamine—Nausea—Vinblastine—breast cancer	0.000123	0.000605	CcSEcCtD
Rescinnamine—Insomnia—Fluorouracil—breast cancer	0.000123	0.000605	CcSEcCtD
Rescinnamine—Hypertension—Paclitaxel—breast cancer	0.000123	0.000603	CcSEcCtD
Rescinnamine—Paraesthesia—Fluorouracil—breast cancer	0.000123	0.000601	CcSEcCtD
Rescinnamine—Pruritus—Vinorelbine—breast cancer	0.000122	0.000599	CcSEcCtD
Rescinnamine—Constipation—Mitoxantrone—breast cancer	0.000122	0.000597	CcSEcCtD
Rescinnamine—Pain—Mitoxantrone—breast cancer	0.000122	0.000597	CcSEcCtD
Rescinnamine—Pain—Irinotecan—breast cancer	0.000122	0.000597	CcSEcCtD
Rescinnamine—Constipation—Irinotecan—breast cancer	0.000122	0.000597	CcSEcCtD
Rescinnamine—Rash—Goserelin—breast cancer	0.000122	0.000596	CcSEcCtD
Rescinnamine—Hypersensitivity—Thiotepa—breast cancer	0.000122	0.000596	CcSEcCtD
Rescinnamine—Dermatitis—Goserelin—breast cancer	0.000122	0.000596	CcSEcCtD
Rescinnamine—Myalgia—Paclitaxel—breast cancer	0.000121	0.000594	CcSEcCtD
Rescinnamine—Headache—Goserelin—breast cancer	0.000121	0.000592	CcSEcCtD
Rescinnamine—Erythema—Docetaxel—breast cancer	0.000121	0.000592	CcSEcCtD
Rescinnamine—Nausea—Tamoxifen—breast cancer	0.00012	0.000588	CcSEcCtD
Rescinnamine—Discomfort—Paclitaxel—breast cancer	0.00012	0.000587	CcSEcCtD
Rescinnamine—Gastritis—Epirubicin—breast cancer	0.00012	0.000586	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000119	0.00372	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—COMT—breast cancer	0.000119	0.00371	CbGpPWpGaD
Rescinnamine—Pain—Gemcitabine—breast cancer	0.000119	0.000582	CcSEcCtD
Rescinnamine—Constipation—Gemcitabine—breast cancer	0.000119	0.000582	CcSEcCtD
Rescinnamine—Dysgeusia—Docetaxel—breast cancer	0.000118	0.000579	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—RPL23A—breast cancer	0.000118	0.00366	CbGpPWpGaD
Rescinnamine—Nausea—Melphalan—breast cancer	0.000117	0.000576	CcSEcCtD
Rescinnamine—Erythema—Capecitabine—breast cancer	0.000117	0.000573	CcSEcCtD
Rescinnamine—Influenza—Epirubicin—breast cancer	0.000117	0.000573	CcSEcCtD
Rescinnamine—Back pain—Docetaxel—breast cancer	0.000117	0.000572	CcSEcCtD
Rescinnamine—Pruritus—Thiotepa—breast cancer	0.000117	0.000572	CcSEcCtD
Rescinnamine—Pain—Fluorouracil—breast cancer	0.000117	0.000572	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Irinotecan—breast cancer	0.000117	0.000571	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000117	0.000571	CcSEcCtD
Rescinnamine—Oedema—Paclitaxel—breast cancer	0.000116	0.00057	CcSEcCtD
Rescinnamine—Infection—Paclitaxel—breast cancer	0.000115	0.000566	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000115	0.00359	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000115	0.00358	CbGpPWpGaD
Rescinnamine—Nausea—Goserelin—breast cancer	0.000115	0.000562	CcSEcCtD
Rescinnamine—Dysgeusia—Capecitabine—breast cancer	0.000114	0.000561	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—BCHE—breast cancer	0.000114	0.00356	CbGpPWpGaD
Rescinnamine—Dizziness—Vinorelbine—breast cancer	0.000114	0.00056	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Methotrexate—breast cancer	0.000114	0.000559	CcSEcCtD
Rescinnamine—Angina pectoris—Epirubicin—breast cancer	0.000114	0.000558	CcSEcCtD
Rescinnamine—Urticaria—Mitoxantrone—breast cancer	0.000113	0.000555	CcSEcCtD
Rescinnamine—Back pain—Capecitabine—breast cancer	0.000113	0.000554	CcSEcCtD
Rescinnamine—Abdominal pain—Mitoxantrone—breast cancer	0.000113	0.000552	CcSEcCtD
Rescinnamine—Abdominal pain—Irinotecan—breast cancer	0.000113	0.000552	CcSEcCtD
Rescinnamine—Bronchitis—Epirubicin—breast cancer	0.000112	0.000551	CcSEcCtD
Rescinnamine—Gastritis—Doxorubicin—breast cancer	0.000111	0.000543	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—RPS8—breast cancer	0.00011	0.00341	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—RPS7—breast cancer	0.00011	0.00341	CbGpPWpGaD
Rescinnamine—Dizziness—Thiotepa—breast cancer	0.000109	0.000535	CcSEcCtD
Rescinnamine—Rash—Vinorelbine—breast cancer	0.000109	0.000534	CcSEcCtD
Rescinnamine—Dermatitis—Vinorelbine—breast cancer	0.000109	0.000534	CcSEcCtD
Rescinnamine—Urticaria—Fluorouracil—breast cancer	0.000108	0.000531	CcSEcCtD
Rescinnamine—Headache—Vinorelbine—breast cancer	0.000108	0.000531	CcSEcCtD
Rescinnamine—Conjunctivitis—Methotrexate—breast cancer	0.000108	0.00053	CcSEcCtD
Rescinnamine—Influenza—Doxorubicin—breast cancer	0.000108	0.00053	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000107	0.00333	CbGpPWpGaD
Rescinnamine—Photosensitivity reaction—Epirubicin—breast cancer	0.000107	0.000523	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000106	0.000519	CcSEcCtD
Rescinnamine—Cough—Docetaxel—breast cancer	0.000105	0.000516	CcSEcCtD
Rescinnamine—Angina pectoris—Doxorubicin—breast cancer	0.000105	0.000516	CcSEcCtD
Rescinnamine—Insomnia—Paclitaxel—breast cancer	0.000105	0.000515	CcSEcCtD
Rescinnamine—Hypersensitivity—Irinotecan—breast cancer	0.000105	0.000515	CcSEcCtD
Rescinnamine—Hypersensitivity—Mitoxantrone—breast cancer	0.000105	0.000515	CcSEcCtD
Rescinnamine—Paraesthesia—Paclitaxel—breast cancer	0.000104	0.000512	CcSEcCtD
Rescinnamine—Hypertension—Docetaxel—breast cancer	0.000104	0.000511	CcSEcCtD
Rescinnamine—Rash—Thiotepa—breast cancer	0.000104	0.00051	CcSEcCtD
Rescinnamine—Bronchitis—Doxorubicin—breast cancer	0.000104	0.00051	CcSEcCtD
Rescinnamine—Dermatitis—Thiotepa—breast cancer	0.000104	0.00051	CcSEcCtD
Rescinnamine—Headache—Thiotepa—breast cancer	0.000103	0.000507	CcSEcCtD
Rescinnamine—Myalgia—Docetaxel—breast cancer	0.000103	0.000504	CcSEcCtD
Rescinnamine—Nausea—Vinorelbine—breast cancer	0.000103	0.000503	CcSEcCtD
Rescinnamine—Cough—Capecitabine—breast cancer	0.000102	0.0005	CcSEcCtD
Rescinnamine—Conjunctivitis—Epirubicin—breast cancer	0.000101	0.000496	CcSEcCtD
Rescinnamine—Urinary tract infection—Epirubicin—breast cancer	0.000101	0.000496	CcSEcCtD
Rescinnamine—Hypertension—Capecitabine—breast cancer	0.000101	0.000495	CcSEcCtD
Rescinnamine—Hypersensitivity—Fluorouracil—breast cancer	0.000101	0.000493	CcSEcCtD
Rescinnamine—Myalgia—Capecitabine—breast cancer	9.95e-05	0.000488	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—IGFBP3—breast cancer	9.94e-05	0.00309	CbGpPWpGaD
Rescinnamine—Constipation—Paclitaxel—breast cancer	9.94e-05	0.000487	CcSEcCtD
Rescinnamine—Pain—Paclitaxel—breast cancer	9.94e-05	0.000487	CcSEcCtD
Rescinnamine—Pharyngitis—Methotrexate—breast cancer	9.92e-05	0.000486	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Doxorubicin—breast cancer	9.87e-05	0.000484	CcSEcCtD
Rescinnamine—Oedema—Docetaxel—breast cancer	9.85e-05	0.000483	CcSEcCtD
Rescinnamine—Discomfort—Capecitabine—breast cancer	9.83e-05	0.000482	CcSEcCtD
Rescinnamine—Pruritus—Gemcitabine—breast cancer	9.82e-05	0.000481	CcSEcCtD
Rescinnamine—Nausea—Thiotepa—breast cancer	9.8e-05	0.00048	CcSEcCtD
Rescinnamine—Infection—Docetaxel—breast cancer	9.78e-05	0.00048	CcSEcCtD
Rescinnamine—Sinusitis—Epirubicin—breast cancer	9.77e-05	0.000479	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—ACHE—breast cancer	9.7e-05	0.00302	CbGpPWpGaD
Rescinnamine—Pruritus—Fluorouracil—breast cancer	9.65e-05	0.000473	CcSEcCtD
Rescinnamine—Oedema—Capecitabine—breast cancer	9.54e-05	0.000467	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Paclitaxel—breast cancer	9.5e-05	0.000466	CcSEcCtD
Rescinnamine—Infection—Capecitabine—breast cancer	9.47e-05	0.000464	CcSEcCtD
Rescinnamine—Dizziness—Irinotecan—breast cancer	9.42e-05	0.000462	CcSEcCtD
Rescinnamine—Rhinitis—Epirubicin—breast cancer	9.37e-05	0.00046	CcSEcCtD
Rescinnamine—Conjunctivitis—Doxorubicin—breast cancer	9.37e-05	0.000459	CcSEcCtD
Rescinnamine—Urinary tract infection—Doxorubicin—breast cancer	9.37e-05	0.000459	CcSEcCtD
Rescinnamine—Hypoaesthesia—Epirubicin—breast cancer	9.3e-05	0.000456	CcSEcCtD
Rescinnamine—Pharyngitis—Epirubicin—breast cancer	9.28e-05	0.000455	CcSEcCtD
Rescinnamine—Urticaria—Paclitaxel—breast cancer	9.23e-05	0.000453	CcSEcCtD
Rescinnamine—Abdominal pain—Paclitaxel—breast cancer	9.19e-05	0.00045	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—CTSD—breast cancer	9.18e-05	0.00286	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—COMT—breast cancer	9.14e-05	0.00284	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—TUBB3—breast cancer	9.1e-05	0.00283	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—THBS1—breast cancer	9.05e-05	0.00281	CbGpPWpGaD
Rescinnamine—Sinusitis—Doxorubicin—breast cancer	9.04e-05	0.000443	CcSEcCtD
Rescinnamine—Dizziness—Fluorouracil—breast cancer	9.02e-05	0.000442	CcSEcCtD
Rescinnamine—Rash—Mitoxantrone—breast cancer	8.98e-05	0.00044	CcSEcCtD
Rescinnamine—Rash—Irinotecan—breast cancer	8.98e-05	0.00044	CcSEcCtD
Rescinnamine—Dermatitis—Irinotecan—breast cancer	8.98e-05	0.00044	CcSEcCtD
Rescinnamine—Dermatitis—Mitoxantrone—breast cancer	8.98e-05	0.00044	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Docetaxel—breast cancer	8.97e-05	0.00044	CcSEcCtD
Rescinnamine—Headache—Mitoxantrone—breast cancer	8.93e-05	0.000438	CcSEcCtD
Rescinnamine—Headache—Irinotecan—breast cancer	8.93e-05	0.000438	CcSEcCtD
Rescinnamine—Insomnia—Docetaxel—breast cancer	8.91e-05	0.000437	CcSEcCtD
Rescinnamine—Paraesthesia—Docetaxel—breast cancer	8.84e-05	0.000434	CcSEcCtD
Rescinnamine—Rash—Gemcitabine—breast cancer	8.75e-05	0.000429	CcSEcCtD
Rescinnamine—Dermatitis—Gemcitabine—breast cancer	8.74e-05	0.000429	CcSEcCtD
Rescinnamine—Erythema—Methotrexate—breast cancer	8.7e-05	0.000426	CcSEcCtD
Rescinnamine—Headache—Gemcitabine—breast cancer	8.69e-05	0.000426	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Capecitabine—breast cancer	8.69e-05	0.000426	CcSEcCtD
Rescinnamine—Rhinitis—Doxorubicin—breast cancer	8.67e-05	0.000425	CcSEcCtD
Rescinnamine—Insomnia—Capecitabine—breast cancer	8.62e-05	0.000423	CcSEcCtD
Rescinnamine—Hypoaesthesia—Doxorubicin—breast cancer	8.61e-05	0.000422	CcSEcCtD
Rescinnamine—Rash—Fluorouracil—breast cancer	8.6e-05	0.000422	CcSEcCtD
Rescinnamine—Dermatitis—Fluorouracil—breast cancer	8.6e-05	0.000421	CcSEcCtD
Rescinnamine—Pharyngitis—Doxorubicin—breast cancer	8.59e-05	0.000421	CcSEcCtD
Rescinnamine—Paraesthesia—Capecitabine—breast cancer	8.56e-05	0.00042	CcSEcCtD
Rescinnamine—Hypersensitivity—Paclitaxel—breast cancer	8.56e-05	0.00042	CcSEcCtD
Rescinnamine—Headache—Fluorouracil—breast cancer	8.55e-05	0.000419	CcSEcCtD
Rescinnamine—Dysgeusia—Methotrexate—breast cancer	8.52e-05	0.000418	CcSEcCtD
Rescinnamine—Nausea—Irinotecan—breast cancer	8.46e-05	0.000415	CcSEcCtD
Rescinnamine—Nausea—Mitoxantrone—breast cancer	8.46e-05	0.000415	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—BCHE—breast cancer	8.45e-05	0.00263	CbGpPWpGaD
Rescinnamine—Pain—Docetaxel—breast cancer	8.42e-05	0.000413	CcSEcCtD
Rescinnamine—Constipation—Docetaxel—breast cancer	8.42e-05	0.000413	CcSEcCtD
Rescinnamine—Back pain—Methotrexate—breast cancer	8.41e-05	0.000412	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—RPS6—breast cancer	8.25e-05	0.00257	CbGpPWpGaD
Rescinnamine—Nausea—Gemcitabine—breast cancer	8.24e-05	0.000404	CcSEcCtD
Rescinnamine—Pruritus—Paclitaxel—breast cancer	8.22e-05	0.000403	CcSEcCtD
Rescinnamine—Pain—Capecitabine—breast cancer	8.15e-05	0.0004	CcSEcCtD
Rescinnamine—Constipation—Capecitabine—breast cancer	8.15e-05	0.0004	CcSEcCtD
Rescinnamine—Erythema—Epirubicin—breast cancer	8.14e-05	0.000399	CcSEcCtD
Rescinnamine—Nausea—Fluorouracil—breast cancer	8.11e-05	0.000397	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Docetaxel—breast cancer	8.05e-05	0.000395	CcSEcCtD
Rescinnamine—Dysgeusia—Epirubicin—breast cancer	7.97e-05	0.000391	CcSEcCtD
Rescinnamine—Back pain—Epirubicin—breast cancer	7.87e-05	0.000386	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—TCF7L2—breast cancer	7.86e-05	0.00245	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Capecitabine—breast cancer	7.8e-05	0.000382	CcSEcCtD
Rescinnamine—Abdominal pain—Docetaxel—breast cancer	7.79e-05	0.000382	CcSEcCtD
Rescinnamine—Dizziness—Paclitaxel—breast cancer	7.68e-05	0.000377	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—BRAF—breast cancer	7.61e-05	0.00237	CbGpPWpGaD
Rescinnamine—Cough—Methotrexate—breast cancer	7.59e-05	0.000372	CcSEcCtD
Rescinnamine—Urticaria—Capecitabine—breast cancer	7.58e-05	0.000371	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	7.57e-05	0.00236	CbGpPWpGaD
Rescinnamine—Abdominal pain—Capecitabine—breast cancer	7.54e-05	0.00037	CcSEcCtD
Rescinnamine—Erythema—Doxorubicin—breast cancer	7.53e-05	0.000369	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCG2—breast cancer	7.42e-05	0.00231	CbGpPWpGaD
Rescinnamine—Myalgia—Methotrexate—breast cancer	7.41e-05	0.000363	CcSEcCtD
Rescinnamine—Dysgeusia—Doxorubicin—breast cancer	7.38e-05	0.000362	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—PLAUR—breast cancer	7.35e-05	0.00229	CbGpPWpGaD
Rescinnamine—Rash—Paclitaxel—breast cancer	7.33e-05	0.000359	CcSEcCtD
Rescinnamine—Dermatitis—Paclitaxel—breast cancer	7.32e-05	0.000359	CcSEcCtD
Rescinnamine—Discomfort—Methotrexate—breast cancer	7.32e-05	0.000359	CcSEcCtD
Rescinnamine—Back pain—Doxorubicin—breast cancer	7.29e-05	0.000357	CcSEcCtD
Rescinnamine—Headache—Paclitaxel—breast cancer	7.28e-05	0.000357	CcSEcCtD
Rescinnamine—Hypersensitivity—Docetaxel—breast cancer	7.26e-05	0.000356	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—PLG—breast cancer	7.19e-05	0.00224	CbGpPWpGaD
Rescinnamine—Cough—Epirubicin—breast cancer	7.1e-05	0.000348	CcSEcCtD
Rescinnamine—Infection—Methotrexate—breast cancer	7.05e-05	0.000346	CcSEcCtD
Rescinnamine—Hypertension—Epirubicin—breast cancer	7.03e-05	0.000345	CcSEcCtD
Rescinnamine—Hypersensitivity—Capecitabine—breast cancer	7.03e-05	0.000344	CcSEcCtD
Rescinnamine—Pruritus—Docetaxel—breast cancer	6.97e-05	0.000342	CcSEcCtD
Rescinnamine—Myalgia—Epirubicin—breast cancer	6.93e-05	0.00034	CcSEcCtD
Rescinnamine—Nausea—Paclitaxel—breast cancer	6.9e-05	0.000338	CcSEcCtD
Rescinnamine—Discomfort—Epirubicin—breast cancer	6.85e-05	0.000336	CcSEcCtD
Rescinnamine—Pruritus—Capecitabine—breast cancer	6.75e-05	0.000331	CcSEcCtD
Rescinnamine—Oedema—Epirubicin—breast cancer	6.64e-05	0.000326	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—TFRC—breast cancer	6.61e-05	0.00206	CbGpPWpGaD
Rescinnamine—Infection—Epirubicin—breast cancer	6.6e-05	0.000324	CcSEcCtD
Rescinnamine—Cough—Doxorubicin—breast cancer	6.57e-05	0.000322	CcSEcCtD
Rescinnamine—Dizziness—Docetaxel—breast cancer	6.51e-05	0.000319	CcSEcCtD
Rescinnamine—Hypertension—Doxorubicin—breast cancer	6.5e-05	0.000319	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Methotrexate—breast cancer	6.47e-05	0.000317	CcSEcCtD
Rescinnamine—Insomnia—Methotrexate—breast cancer	6.42e-05	0.000315	CcSEcCtD
Rescinnamine—Myalgia—Doxorubicin—breast cancer	6.41e-05	0.000314	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—MDM2—breast cancer	6.38e-05	0.00198	CbGpPWpGaD
Rescinnamine—Paraesthesia—Methotrexate—breast cancer	6.37e-05	0.000312	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—NCOA2—breast cancer	6.36e-05	0.00198	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—RAF1—breast cancer	6.36e-05	0.00198	CbGpPWpGaD
Rescinnamine—Discomfort—Doxorubicin—breast cancer	6.34e-05	0.000311	CcSEcCtD
Rescinnamine—Dizziness—Capecitabine—breast cancer	6.31e-05	0.000309	CcSEcCtD
Rescinnamine—Rash—Docetaxel—breast cancer	6.21e-05	0.000304	CcSEcCtD
Rescinnamine—Dermatitis—Docetaxel—breast cancer	6.2e-05	0.000304	CcSEcCtD
Rescinnamine—Headache—Docetaxel—breast cancer	6.17e-05	0.000302	CcSEcCtD
Rescinnamine—Oedema—Doxorubicin—breast cancer	6.15e-05	0.000301	CcSEcCtD
Rescinnamine—Infection—Doxorubicin—breast cancer	6.11e-05	0.000299	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	6.07e-05	0.00189	CbGpPWpGaD
Rescinnamine—Pain—Methotrexate—breast cancer	6.07e-05	0.000298	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Epirubicin—breast cancer	6.05e-05	0.000297	CcSEcCtD
Rescinnamine—Rash—Capecitabine—breast cancer	6.01e-05	0.000295	CcSEcCtD
Rescinnamine—Insomnia—Epirubicin—breast cancer	6.01e-05	0.000295	CcSEcCtD
Rescinnamine—Dermatitis—Capecitabine—breast cancer	6.01e-05	0.000294	CcSEcCtD
Rescinnamine—Headache—Capecitabine—breast cancer	5.97e-05	0.000293	CcSEcCtD
Rescinnamine—Paraesthesia—Epirubicin—breast cancer	5.97e-05	0.000292	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	5.86e-05	0.00182	CbGpPWpGaD
Rescinnamine—Nausea—Docetaxel—breast cancer	5.85e-05	0.000287	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—BRAF—breast cancer	5.83e-05	0.00182	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Methotrexate—breast cancer	5.8e-05	0.000285	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—ALB—breast cancer	5.7e-05	0.00177	CbGpPWpGaD
Rescinnamine—Pain—Epirubicin—breast cancer	5.68e-05	0.000279	CcSEcCtD
Rescinnamine—Constipation—Epirubicin—breast cancer	5.68e-05	0.000279	CcSEcCtD
Rescinnamine—Nausea—Capecitabine—breast cancer	5.66e-05	0.000278	CcSEcCtD
Rescinnamine—Urticaria—Methotrexate—breast cancer	5.64e-05	0.000276	CcSEcCtD
Rescinnamine—Abdominal pain—Methotrexate—breast cancer	5.61e-05	0.000275	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.6e-05	0.000275	CcSEcCtD
Rescinnamine—Insomnia—Doxorubicin—breast cancer	5.56e-05	0.000273	CcSEcCtD
Rescinnamine—Paraesthesia—Doxorubicin—breast cancer	5.52e-05	0.000271	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Epirubicin—breast cancer	5.43e-05	0.000266	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—NCOA1—breast cancer	5.36e-05	0.00167	CbGpPWpGaD
Rescinnamine—Urticaria—Epirubicin—breast cancer	5.28e-05	0.000259	CcSEcCtD
Rescinnamine—Pain—Doxorubicin—breast cancer	5.26e-05	0.000258	CcSEcCtD
Rescinnamine—Constipation—Doxorubicin—breast cancer	5.26e-05	0.000258	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—MMP1—breast cancer	5.25e-05	0.00163	CbGpPWpGaD
Rescinnamine—Abdominal pain—Epirubicin—breast cancer	5.25e-05	0.000257	CcSEcCtD
Rescinnamine—Hypersensitivity—Methotrexate—breast cancer	5.23e-05	0.000256	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—PLG—breast cancer	5.23e-05	0.00163	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—LEP—breast cancer	5.08e-05	0.00158	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Doxorubicin—breast cancer	5.03e-05	0.000246	CcSEcCtD
Rescinnamine—Pruritus—Methotrexate—breast cancer	5.02e-05	0.000246	CcSEcCtD
Rescinnamine—Hypersensitivity—Epirubicin—breast cancer	4.89e-05	0.00024	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—MDM2—breast cancer	4.89e-05	0.00152	CbGpPWpGaD
Rescinnamine—Urticaria—Doxorubicin—breast cancer	4.88e-05	0.000239	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—RAF1—breast cancer	4.87e-05	0.00152	CbGpPWpGaD
Rescinnamine—Abdominal pain—Doxorubicin—breast cancer	4.86e-05	0.000238	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—HMOX1—breast cancer	4.82e-05	0.0015	CbGpPWpGaD
Rescinnamine—Pruritus—Epirubicin—breast cancer	4.7e-05	0.00023	CcSEcCtD
Rescinnamine—Dizziness—Methotrexate—breast cancer	4.69e-05	0.00023	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—breast cancer	4.63e-05	0.00144	CbGpPWpGaD
Rescinnamine—Hypersensitivity—Doxorubicin—breast cancer	4.53e-05	0.000222	CcSEcCtD
Rescinnamine—Rash—Methotrexate—breast cancer	4.48e-05	0.000219	CcSEcCtD
Rescinnamine—Dermatitis—Methotrexate—breast cancer	4.47e-05	0.000219	CcSEcCtD
Rescinnamine—Headache—Methotrexate—breast cancer	4.45e-05	0.000218	CcSEcCtD
Rescinnamine—Dizziness—Epirubicin—breast cancer	4.39e-05	0.000215	CcSEcCtD
Rescinnamine—Pruritus—Doxorubicin—breast cancer	4.35e-05	0.000213	CcSEcCtD
Rescinnamine—Nausea—Methotrexate—breast cancer	4.22e-05	0.000207	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—IGF1—breast cancer	4.2e-05	0.00131	CbGpPWpGaD
Rescinnamine—Rash—Epirubicin—breast cancer	4.19e-05	0.000205	CcSEcCtD
Rescinnamine—Dermatitis—Epirubicin—breast cancer	4.18e-05	0.000205	CcSEcCtD
Rescinnamine—Headache—Epirubicin—breast cancer	4.16e-05	0.000204	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—MMP2—breast cancer	4.07e-05	0.00127	CbGpPWpGaD
Rescinnamine—Dizziness—Doxorubicin—breast cancer	4.06e-05	0.000199	CcSEcCtD
Rescinnamine—Nausea—Epirubicin—breast cancer	3.95e-05	0.000193	CcSEcCtD
Rescinnamine—Rash—Doxorubicin—breast cancer	3.88e-05	0.00019	CcSEcCtD
Rescinnamine—Dermatitis—Doxorubicin—breast cancer	3.87e-05	0.00019	CcSEcCtD
Rescinnamine—Headache—Doxorubicin—breast cancer	3.85e-05	0.000189	CcSEcCtD
Rescinnamine—Nausea—Doxorubicin—breast cancer	3.65e-05	0.000179	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—HRAS—breast cancer	3.5e-05	0.00109	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CXCL8—breast cancer	3.38e-05	0.00105	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CTNNB1—breast cancer	3.12e-05	0.00097	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ALB—breast cancer	2.9e-05	0.000901	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—HRAS—breast cancer	2.68e-05	0.000834	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—RAF1—breast cancer	2.62e-05	0.000815	CbGpPWpGaD
